|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4789633A
(en)
|
1984-04-19 |
1988-12-06 |
University Of Tennessee Research Corporation |
Fused liposome and acid induced method for liposome fusion
|
|
US4925661A
(en)
|
1984-04-19 |
1990-05-15 |
Leaf Huang |
Target-specific cytotoxic liposomes
|
|
JPH0662517B2
(ja)
|
1985-01-07 |
1994-08-17 |
シンテツクス(ユー・エス・エイ)インコーポレイテツド |
置換アルキルートリ置換アンモニウム界面活性剤
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4983397A
(en)
|
1985-08-19 |
1991-01-08 |
Board Of Regents, University Of Texas System |
Pharmaceutical compositions consisting of acylated phospholipids
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
JPS63182029A
(ja)
|
1987-01-22 |
1988-07-27 |
Agency Of Ind Science & Technol |
リポソ−ム
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5049390A
(en)
|
1987-09-02 |
1991-09-17 |
Allergy Immuno Technologies, Inc. |
Liposome containing immunotherapy agents for treating IgE mediated allergies
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
JPH0720857B2
(ja)
|
1988-08-11 |
1995-03-08 |
テルモ株式会社 |
リポソームおよびその製法
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DK0737750T3
(da)
|
1989-03-21 |
2003-09-01 |
Vical Inc |
Ekspression af exogene polynucleotidsekvenser i vertebrater
|
|
US5474772A
(en)
|
1989-08-02 |
1995-12-12 |
Cobe Laboratories, Inc. |
Method of treatment with medical agents
|
|
CA2025907A1
(en)
|
1989-09-21 |
1991-03-22 |
Franklin D. Collins |
Method of transporting compositions across the blood brain barrier
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
WO1992007959A1
(en)
|
1990-11-05 |
1992-05-14 |
Biowhittaker Inc. |
Homogeneous membrane lytic immunoassay method utilizing contact sensitive liposome formulations
|
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
US6509032B1
(en)
|
1991-08-28 |
2003-01-21 |
Mcmaster University |
Cationic amphiphiles
|
|
US5292524A
(en)
|
1991-09-06 |
1994-03-08 |
California Institute Of Technology |
Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
JPH07503132A
(ja)
|
1991-12-17 |
1995-04-06 |
ジェンファーム インターナショナル,インコーポレイティド |
異種抗体を産生することができるトランスジェニック非ヒト動物
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
JPH07505283A
(ja)
|
1992-03-20 |
1995-06-15 |
ベイラー・カレッジ・オブ・メディシン |
Dnaトランスポーター系および使用方法
|
|
AU682308C
(en)
|
1992-04-03 |
2006-08-17 |
Regents Of The University Of California, The |
Self-assembling polynucleotide delivery system
|
|
AU4116793A
(en)
|
1992-04-24 |
1993-11-29 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
AU6819494A
(en)
|
1993-04-26 |
1994-11-21 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
SG54115A1
(en)
|
1993-04-27 |
1998-11-16 |
Gerber Scient Products Inc |
Thermal printing apparatus with improved power supply
|
|
AU691811B2
(en)
|
1993-06-16 |
1998-05-28 |
Celltech Therapeutics Limited |
Antibodies
|
|
CA2163364C
(en)
|
1993-07-14 |
2009-10-27 |
Francis C. Szoka, Jr. |
Self-assembling polynucleotide delivery system comprising dendrimer polycations
|
|
US5534241A
(en)
|
1993-07-23 |
1996-07-09 |
Torchilin; Vladimir P. |
Amphipathic polychelating compounds and methods of use
|
|
US6087171A
(en)
|
1993-12-17 |
2000-07-11 |
Spinal Cord Society |
Method for inducing DNA synthesis in neurons
|
|
US5830686A
(en)
|
1994-01-13 |
1998-11-03 |
Calydon |
Tissue-specific enhancer active in prostate
|
|
US6057299A
(en)
|
1994-01-13 |
2000-05-02 |
Calydon, Inc. |
Tissue-specific enhancer active in prostate
|
|
US5651981A
(en)
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
|
WO1995031183A1
(en)
*
|
1994-05-16 |
1995-11-23 |
Washington University |
Cell membrane fusion composition and method
|
|
US6110666A
(en)
|
1994-06-09 |
2000-08-29 |
Medical Research Council |
Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US5527928A
(en)
|
1994-09-30 |
1996-06-18 |
Nantz; Michael H. |
Cationic transport reagents
|
|
WO1996013250A1
(en)
|
1994-10-27 |
1996-05-09 |
Amgem Inc. |
Compositions for increased bioavailability of orally delivered therapeutic agents
|
|
US5786214A
(en)
|
1994-12-15 |
1998-07-28 |
Spinal Cord Society |
pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
|
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5780052A
(en)
|
1995-04-24 |
1998-07-14 |
Northeastern University |
Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell
|
|
US5834012A
(en)
|
1995-05-03 |
1998-11-10 |
Roman Perez-Soler |
Lipid complexed topoisomerase I inhibitors
|
|
JP3735921B2
(ja)
|
1996-02-07 |
2006-01-18 |
三菱ウェルファーマ株式会社 |
GPIb・脂質複合体およびその用途
|
|
US6077834A
(en)
|
1996-02-09 |
2000-06-20 |
Cheng; Pi-Wan |
Receptor ligand-facilitated delivery of biologically active molecules
|
|
EP0914094A4
(en)
|
1996-03-28 |
2000-03-01 |
Univ Illinois |
MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS
|
|
WO1997038010A2
(en)
|
1996-04-11 |
1997-10-16 |
The University Of British Columbia |
Fusogenic liposomes
|
|
JP3919227B2
(ja)
|
1996-05-02 |
2007-05-23 |
テルモ株式会社 |
アミジン誘導体及びそれを構成成分とする薬物担体
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
ATE252372T1
(de)
|
1996-08-23 |
2003-11-15 |
Sequus Pharm Inc |
Liposome enthaltend cisplatin
|
|
US7384923B2
(en)
|
1999-05-14 |
2008-06-10 |
Lipoxen Technologies Limited |
Liposomes
|
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
TW520297B
(en)
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
|
US6153596A
(en)
|
1996-12-18 |
2000-11-28 |
Emory University |
Polycationic oligomers
|
|
EA002630B1
(ru)
|
1997-02-05 |
2002-08-29 |
Фармация Энд Апджон Компани |
Способ получения липидных комплексов или липосом водонерастворимого диаминоциклогександикарбоксилата платины
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US6524613B1
(en)
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
JP3614866B2
(ja)
|
1997-06-12 |
2005-01-26 |
リサーチ コーポレイション テクノロジーズ,インコーポレイティド |
人工抗体ポリペプチド
|
|
DE69838584T2
(de)
|
1997-08-04 |
2008-06-26 |
Cell Genesys, Inc., Foster City |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
|
US6749863B1
(en)
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
ES2339421T3
(es)
|
1997-11-19 |
2010-05-20 |
Georgetown University |
Administracion genica mediante liposoma dirigido.
|
|
AU1656799A
(en)
|
1997-12-12 |
1999-07-05 |
Inex Pharmaceuticals Corp. |
Cationic drugs encapsulated in anionic liposomes
|
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
|
US6573101B1
(en)
|
1998-02-12 |
2003-06-03 |
The Regents Of The University Of California |
Compositions for receptor/liposome mediated transfection and methods of using same
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
JP4334141B2
(ja)
|
1998-04-20 |
2009-09-30 |
グリカート バイオテクノロジー アクチェンゲゼルシャフト |
抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
|
|
US6245427B1
(en)
|
1998-07-06 |
2001-06-12 |
DüZGüNES NEJAT |
Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
|
|
HUP0104865A3
(en)
|
1999-01-15 |
2004-07-28 |
Genentech Inc |
Polypeptide variants with altered effector function
|
|
US7311924B2
(en)
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
US6723338B1
(en)
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
DE19925143A1
(de)
|
1999-06-02 |
2000-12-07 |
Aventis Pharma Gmbh |
Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie
|
|
JP2001002592A
(ja)
|
1999-06-18 |
2001-01-09 |
Dai Ichi Seiyaku Co Ltd |
遺伝子導入用組成物
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
AU1776801A
(en)
|
1999-11-24 |
2001-06-04 |
Liposome Company, Inc., The |
Modular targeted liposomal delivery system
|
|
EP1242609A2
(en)
|
1999-12-30 |
2002-09-25 |
Novartis AG |
Novel colloid synthetic vectors for gene therapy
|
|
CA2733819A1
(en)
|
1999-12-30 |
2001-07-12 |
Judith K. Gwathmey |
Iron chelator delivery system
|
|
US6530944B2
(en)
|
2000-02-08 |
2003-03-11 |
Rice University |
Optically-active nanoparticles for use in therapeutic and diagnostic methods
|
|
DE60130741T2
(de)
|
2000-03-02 |
2008-07-03 |
Mitsubishi Pharma Corp. |
GPib-GEBUNDENES KONSTRUKT UND VERWENDUNGEN DAVON
|
|
DK1272160T3
(da)
|
2000-04-12 |
2007-05-21 |
Liplasome Pharma As |
Lipidbaseret lægemiddelleveringssystem til topisk applikation
|
|
JP2004511426A
(ja)
|
2000-05-03 |
2004-04-15 |
ミュンヘン バイオテク アーゲー |
活性化血管部位に関連する陽イオン性の診断薬、画像化剤、および治療薬
|
|
US20030059461A1
(en)
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US20040234588A1
(en)
|
2000-09-21 |
2004-11-25 |
University Of Georgia Research Foundation, Inc. |
Artificial lipoprotein carrier system for bioactive materials
|
|
EP1209469A1
(en)
|
2000-11-22 |
2002-05-29 |
Vectron Therapeutics AG |
Production and use of a targeted diagnostic system
|
|
DE60131456T2
(de)
|
2000-11-30 |
2008-07-10 |
Medarex, Inc., Milpitas |
Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern
|
|
JP2004524516A
(ja)
|
2000-12-12 |
2004-08-12 |
オーストラリアン インスティチュート オブ マリーン サイエンス |
麻痺性貝毒のアッセイ
|
|
US6897196B1
(en)
|
2001-02-07 |
2005-05-24 |
The Regents Of The University Of California |
pH sensitive lipids based on ortho ester linkers, composition and method
|
|
FI113840B
(fi)
|
2001-03-26 |
2004-06-30 |
Ctt Cancer Targeting Tech Oy |
Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
|
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
|
JP2004535388A
(ja)
|
2001-04-30 |
2004-11-25 |
ターゲティッド ジェネティクス コーポレイション |
脂質含有薬物送達複合体およびそれらの生成方法
|
|
WO2002089772A1
(en)
|
2001-05-09 |
2002-11-14 |
Inex Pharmaceuticals Corporation |
Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents
|
|
JP2004532038A
(ja)
|
2001-05-17 |
2004-10-21 |
ディヴァーサ コーポレイション |
新規抗原結合分子の治療、診断、予防、酵素、産業ならびに農業各分野への応用とそのための新規抗原結合分子の作製とスクリーニングの方法
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
AU2002330139A1
(en)
|
2001-10-03 |
2003-04-14 |
Vanderbilt University |
In vivo panning for ligands to radiation-induced molecules
|
|
PL213948B1
(pl)
|
2001-10-25 |
2013-05-31 |
Genentech Inc |
Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje
|
|
WO2003044214A2
(en)
|
2001-11-20 |
2003-05-30 |
Baylor College Of Medicine |
Methods and compositions in checkpoint signaling
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
US20030228285A1
(en)
|
2002-05-03 |
2003-12-11 |
Mien-Chie Hung |
Bipartite T-cell factor (Tcf)-responsive promoter
|
|
US20040022842A1
(en)
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
JP3415131B1
(ja)
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
EP1519714B1
(en)
|
2002-06-28 |
2010-10-20 |
Protiva Biotherapeutics Inc. |
Method and apparatus for producing liposomes
|
|
MXPA05003983A
(es)
|
2002-10-16 |
2005-06-22 |
Scripps Research Inst |
Incorporacion en sitio especifico de cetoaminoacidos en proteinas.
|
|
EP1558747B1
(en)
|
2002-10-16 |
2009-10-14 |
The Scripps Research Institute |
Glycoprotein synthesis
|
|
EA008497B1
(ru)
|
2002-11-21 |
2007-06-29 |
Певион Биотех Лтд. |
Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая
|
|
JP5642916B2
(ja)
|
2003-04-17 |
2014-12-17 |
ザ スクリプス リサーチ インスティテュート |
真核遺伝コードの拡張
|
|
EP1704242A4
(en)
|
2003-07-07 |
2008-06-18 |
Scripps Research Inst |
COMPOSITIONS WITH PAIRS OF ORTHOGONAL LEUCYL-TRNA AND AMINOACYL-TRNA-SYNTHETASE AND USES THEREOF
|
|
WO2005007624A2
(en)
|
2003-07-07 |
2005-01-27 |
The Scripps Research Institute |
Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
|
|
US7947493B2
(en)
|
2003-07-09 |
2011-05-24 |
Wisconsin Alumni Research Foundation |
Compositions and methods for regulating mRNA transcription and translation
|
|
US7981843B2
(en)
|
2004-01-20 |
2011-07-19 |
Kalobios Pharmaceuticals, Inc. |
Antibody specificity transfer using minimal essential binding determinants
|
|
MX2007003142A
(es)
|
2004-09-21 |
2007-07-04 |
Scripps Research Inst |
Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
|
|
MX2007004892A
(es)
|
2004-10-27 |
2007-08-16 |
Scripps Research Inst |
Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales.
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
JP5603012B2
(ja)
|
2005-12-02 |
2014-10-08 |
トヘ モウント シナイ スクール オフ メディシネ オフ ニューヨーク ウニベルシトイ |
非天然表面タンパク質を提示するキメラウイルス及びその使用
|
|
MX2008011470A
(es)
|
2006-03-09 |
2008-09-24 |
Scripps Research Inst |
Sistemas para la expresion de componentes de traduccion ortogonales en celulas huesped eubacterianas.
|
|
GB0606954D0
(en)
*
|
2006-04-06 |
2006-05-17 |
Randox Lab Ltd |
Method
|
|
CN101583346B
(zh)
|
2006-04-28 |
2015-08-19 |
儿童医院医疗中心 |
用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质
|
|
WO2008140621A2
(en)
|
2006-12-21 |
2008-11-20 |
Mount Sinai School Of Medicine Of New York University |
Transgenic oncolytic viruses and uses thereof
|
|
EP2118150B1
(en)
|
2007-02-14 |
2015-09-23 |
Biocompatibles UK Limited |
Derivatisation of biological molecules
|
|
CA2688804A1
(en)
|
2008-12-17 |
2010-06-17 |
The Uab Research Foundation |
Polycistronic vector for human induced pluripotent stem cell production
|
|
EP2393921B1
(en)
|
2009-02-05 |
2015-07-15 |
Icahn School of Medicine at Mount Sinai |
Chimeric newcastle disease viruses and uses thereof
|
|
FR2945538B1
(fr)
|
2009-05-12 |
2014-12-26 |
Sanofi Aventis |
Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide.
|
|
CA2813300A1
(en)
|
2010-09-29 |
2012-04-05 |
Innovascreen Inc. |
Recombinant polypeptides for membrane fusion and uses thereof
|
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
|
|
WO2013078433A1
(en)
|
2011-11-23 |
2013-05-30 |
University Of Hawaii |
Auto-processing domains for polypeptide expression
|
|
EP2807274B1
(en)
*
|
2012-01-27 |
2019-01-23 |
Vib Vzw |
Monocyte biomarkers for cancer detection
|
|
PE20151921A1
(es)
|
2013-03-14 |
2015-12-26 |
Icahn School Med Mount Sinai |
Virus de la enfermedad de newcastle y usos de los mismos
|
|
WO2014210448A1
(en)
*
|
2013-06-27 |
2014-12-31 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods relating to myomaker-induced muscle cell fusion
|